Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed through a tissue sample, and who are planned to receive immunotherapy (either alone or combined with other treatments) for advanced or spread cancer.
- People who have areas of cancer that can be measured on scans.
- People who are reasonably active and able to care for themselves, ranging from fully active to capable of limited self-care (this is measured on a standard scale called ECOG, scores 0, 1, or 2 — confirm with trial site if unsure where this applies).
- People who are willing to have their follow-up care at the University of Iowa.
Who may not be able to join:
- People who have serious other health conditions that the trial doctors believe could interfere with the goals of the study.
- People who are pregnant or currently breastfeeding.
- People who experience severe claustrophobia (extreme fear of enclosed spaces), which may affect the ability to undergo scanning procedures.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muhammad Furqan, M.D., Holden Comprehensive Cancer Center
Phone: 319-356-1445
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[18F]F-AraG Quantification; [18F]F AraG Correlation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.